Insmed Incorporated (INSM)
| Previous close | 25.95 |
| Open | 26.15 |
| Bid | 25.89 x 200 |
| Ask | 26.03 x 600 |
| Day's range | 25.61 - 26.21 |
| 52-week range | 18.09 - 32.00 |
| Volume | |
| Avg. volume | 1,787,803 |
| Market cap | 3.859B |
| Beta (5Y monthly) | 0.92 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -5.34 |
| Earnings date | 09 May 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 44.13 |
PR NewswireInsmed To Present at the BofA Securities Health Care Conference 2024
Insmed Incorporated (Nasdaq:INSM), a global biopharmaceutical company on a mission to transform the lives of patients with serious and rare diseases, today announced that management will present in a fireside chat at the BofA Securities Health Care Conference 2024 in Las Vegas, NV, on Tuesday, May 14, 2024 at 2:20 p.m. PT (5:20 p.m. ET).
Simply Wall St.We Think Some Shareholders May Hesitate To Increase Insmed Incorporated's (NASDAQ:INSM) CEO Compensation
Key Insights Insmed to hold its Annual General Meeting on 13th of May Salary of US$780.0k is part of CEO Will Lewis's...
- PR Newswire
Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
Insmed Incorporated (Nasdaq: INSM), a global biopharmaceutical company on a mission to transform the lives of patients with serious and rare diseases, today announced the granting of inducement awards to 63 new employees. In accordance with NASDAQ Listing Rule 5635(c)(4), the awards were approved by Insmed's Compensation Committee and made as a material inducement to each employee's entry into employment with the Company.
